Designing a new drug is not enough; it has to be delivered to its target, which can be achieved via a cornucopia of vehicles, from nanoparticles and microneedles to red blood cells and microalgae.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Shortwave-infrared-light-emitting probes for the in vivo tracking of cancer vaccines and the elicited immune responses
Nature Biomedical Engineering Open Access 24 August 2023
-
Regulatory safety evaluation of nanomedical products: key issues to refine
Drug Delivery and Translational Research Open Access 30 July 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
24,99 € / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
212,91 € per year
only 17,74 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
May, M. Why drug delivery is the key to new medicines. Nat Med 28, 1100–1102 (2022). https://doi.org/10.1038/s41591-022-01826-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-022-01826-y
This article is cited by
-
A review of recent advances in the stability, efficacy, and biosafety of black phosphorus-based drug delivery
Journal of Materials Science (2024)
-
Shortwave-infrared-light-emitting probes for the in vivo tracking of cancer vaccines and the elicited immune responses
Nature Biomedical Engineering (2023)
-
Regulatory safety evaluation of nanomedical products: key issues to refine
Drug Delivery and Translational Research (2022)